近日,美国加州中区联邦法院对强生集团旗下电生理子公司 Biosense Webster 作出裁决,认定其通过非法垄断手段打压第三方医疗器械再处理企业,将初始赔偿金额从1.47亿美元(约合人民币10.5亿元)三倍赔偿至4.42亿美元(约合人民币32亿元)。这场可追溯至 2019 年的六年法律战终于尘埃落定。01三倍赔偿,六年诉讼的终极惩罚此次案件的核心在于强生旗下 Biosense Webster ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.